Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?

Lisa M. Lima, Keeran Sampat, Sarit Assouline, Debra Saxe, Sharron Nault, Mourad Tighiouart, Morgan McLemor, Martha Arellano, Elliott Winton, Leon Bernal-Mizrachi, Jorge Cortes, Hanna Jean Khoury

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?'. Together they form a unique fingerprint.

Medicine & Life Sciences